Valuation : IRIDEX Corporation

Market Cap 11.86M 10.2M 9.62M 8.77M 16.39M 1.13B 16.53M 115M 44.1M 575M 44.53M 43.56M 1.83B P/E 2026 *
-5.63x
P/E 2027 * -
Enterprise Value 11.86M 10.2M 9.62M 8.77M 16.39M 1.13B 16.53M 115M 44.1M 575M 44.53M 43.56M 1.83B EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.21x
Free-Float
61.18%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week-3.65%
Current month-6.70%
1 month-19.81%
3 months-40.26%
6 months-49.62%
Current year-40.78%
1 week 0.66
Extreme 0.66
0.71
1 month 0.66
Extreme 0.66
0.98
Current year 0.66
Extreme 0.66
1.65
1 year 0.66
Extreme 0.66
1.65
3 years 0.66
Extreme 0.66
3.65
5 years 0.66
Extreme 0.66
9.46
10 years 0.66
Extreme 0.66
16.39
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Financial Officer

6,668 0.0383%
10/07/26 Free

Chief Financial Officer

200,000 1.1490%
10/07/26 Free

Chief Executive Officer

400,000 2.2980%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-3.65%-48.92%-64.09% 11.94M
-0.41%-2.47%+26.57%+16.38% 224B
-2.11%-4.98%+4.12%-19.26% 144B
+2.04%-2.53%-19.89%+20.87% 125B
-4.14%-8.20%-59.04%-19.99% 65.16B
-0.70%-1.00%-20.42%-13.99% 50.05B
+0.68%-3.35%+10.85%+17.15% 49.67B
-1.13%-4.57%+15.31%+25.55% 40.81B
-0.78%-2.88%+37.06%+52.38% 39.77B
-1.82%-9.20%+110.78%+27.10% 30.96B
Average -0.76%-3.88%+5.64%+4.21% 76.92B
Weighted average by Cap. -0.70%-3.34%+6.84%+8.21%

Financials

2026 *2027 *
Net sales 52.52M 45.17M 42.62M 38.82M 72.58M 5.02B 73.24M 508M 195M 2.55B 197M 193M 8.09B 55.98M 48.14M 45.42M 41.38M 77.35M 5.35B 78.05M 541M 208M 2.71B 210M 206M 8.62B
Net income -2.09M -1.79M -1.69M -1.54M -2.88M -199M -2.91M -20.16M -7.76M -101M -7.83M -7.66M -321M 1K 860 811.43 739.21 1.38K 95.61K 1.39K 9.66K 3.72K 48.49K 3.76K 3.67K 154K
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
10/09/26 $0.6751 -0.72% 102,153
09/09/26 $0.6800 -0.35% 41,668
08/09/26 $0.6824 -2.51% 89,162
04/09/26 $0.7000 -0.10% 78,324
03/09/26 $0.7007 -2.83% 70,141
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6751USD
Average target price
2.750USD
Spread / Average Target
+307.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!